Point72 Asset Management »

Eliem Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Eliem Therapeutics (ELYM) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.0M 591k 5.09
2022-03-31 $1.2M 142k 8.39

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Shell Spon Ads (SHEL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Arista Networks (ANET)
Comcast Corp Cl A (CMCSA)
Boston Scientific Corporation (BSX)
M/a (MTSI)
Lumentum Hldgs (LITE)
Intuitive Surgical Com New (ISRG)
Alphabet Cap Stk Cl A (GOOGL)
ConocoPhillips (COP)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Eliem Therapeutics

RA Capital Management
Deep Track Capital
Henderson Group
Samsara BioCapital
Boxer Capital
BlackRock
Affinity Asset Advisors
T. Rowe Price Associates
Geode Capital Management
Driehaus Capital Management
Point72 Asset Management
Nan Fung Group Holdings
BlackRock
Vanguard Group
Northern Trust

View all funds holding Eliem Therapeutics